ALLIANCEBERNSTEIN L.P. - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 66 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q1 2022$96,000
-47.8%
34,600
+0.3%
0.00%
Q4 2021$184,000
-37.0%
34,5000.0%0.00%
Q3 2021$292,000
-30.6%
34,5000.0%0.00%
Q2 2021$421,000
+16.6%
34,500
+131.5%
0.00%
Q1 2021$361,000
-24.5%
14,9000.0%0.00%
Q4 2020$478,000
+10.6%
14,900
+4.2%
0.00%
Q3 2020$432,000
-32.2%
14,300
-5.3%
0.00%
Q2 2020$637,000
+186.9%
15,100
+69.7%
0.00%
Q1 2020$222,0008,9000.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q1 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$86,074,0004.50%
Boxer Capital, LLC 2,014,858$50,271,0003.43%
RA Capital Management 2,589,904$64,618,0002.04%
Artal Group S.A. 1,696,517$42,328,0001.79%
Logos Global Management LP 123,465$2,772,0001.05%
BVF INC/IL 378,788$9,451,0000.88%
Casdin Capital, LLC 289,395$7,220,0000.77%
Perceptive Advisors 1,104,656$27,561,0000.72%
Bellevue Group AG 1,330,000$33,184,0000.64%
Vivo Capital, LLC 252,119$6,290,0000.57%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders